Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 28 citing articles:

Vascular leak in sepsis: physiological basis and potential therapeutic advances
Ross R. McMullan, Daniel F. McAuley, Cecilia M. O’Kane, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 19
Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
Madina Sarsenova, Yevgeniy Kim, Kamila Raziyeva, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review
An Duong, Gaganvir Parmar, Aidan M. Kirkham, et al.
Cytotherapy (2023) Vol. 25, Iss. 9, pp. 939-945
Closed Access | Times Cited: 35
Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery
Pedro Silva Couto, Nada Al-Arawe, Igor Salerno Filgueiras, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial
Ellen Gorman, Jennifer Rynne, Hannah J. Gardiner, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 3, pp. 256-269
Open Access | Times Cited: 12
Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
Gerard F. Curley, Cecilia M. O’Kane, Daniel F. McAuley, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 7, pp. 789-797
Open Access | Times Cited: 4
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
Aidan M. Kirkham, Adrian Bailey, Risa Shorr, et al.
Cytotherapy (2022) Vol. 25, Iss. 3, pp. 341-352
Open Access | Times Cited: 15
Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives
Sabrina Mattoli, M. Schmidt
Advances in Therapy (2023) Vol. 40, Iss. 6, pp. 2626-2692
Open Access | Times Cited: 8
Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial
María Esther Martínez-Muñoz, Concepción Payares‐Herrera, I. Lipperheide, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 777-784
Open Access | Times Cited: 2
Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis
Giulia Gazzaniga, M Voltini, Alessandro Carletti, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry
Daniel J. Weiss, Anthony J. Filiano, Jacques Galipeau, et al.
Cytotherapy (2022) Vol. 24, Iss. 11, pp. 1071-1073
Open Access | Times Cited: 10
Prophylactic Administration of Mesenchymal Stromal Cells Does Not Prevent Arrested Lung Development in Extremely Premature-Born Non-Human Primates
Marius A. Möbius, S Seidner, Donald McCurnin, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 2, pp. 97-111
Open Access | Times Cited: 5
Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes
Maryanne C. Herzig, Barbara A. Christy, Robbie K. Montgomery, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
A living critical interpretive synthesis to yield a framework on the production and dissemination of living evidence syntheses for decision-making
Cristián Mansilla, Qi Wang, Thomas Piggott, et al.
Implementation Science (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics
Denise Battaglini, Fernanda F. Cruz, Chiara Robba, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 995-1015
Closed Access | Times Cited: 6
Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome
Cecilia M. O’Kane, Michael A. Matthay
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 3, pp. 231-233
Open Access | Times Cited: 6
What is the need and why is it time for innovative models for understanding lung repair and regeneration?
Daniel J. Weiss
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome
Francisca Alcayaga‐Miranda, Johnatas D. Silva, Nicol Parada, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 2
Current and Emerging Therapies for COVID-19 in Lung Transplantation
Daniel Friedman, Natasha N. Pettit, Erica L. MacKenzie, et al.
Current Pulmonology Reports (2023) Vol. 12, Iss. 2, pp. 23-35
Open Access | Times Cited: 2
Incorporating Stem Cells Into Physical Rehabilitation
Quan Fu Gan, Pooi Pooi Leong, Soon Keng Cheong, et al.
Elsevier eBooks (2024), pp. 407-430
Closed Access
Stem cell therapy for COVID-19 treatment: An umbrella review
Chaozhi Tang, Arkadiusz Dziedzic, Mahalaqua Nazli Khatib, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 10, pp. 6402-6417
Open Access
Mesenchymal Stromal Cells in Acute Respiratory Distress Syndrome: More Questions Than Answers
Jonathan Millar, Cecilia M. O’Kane
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 12, pp. 1257-1259
Open Access | Times Cited: 1
MSC-Based Cell Therapy for COVID-19-Associated ARDS and Classical ARDS: Comparative Perspectives
Daniel J. Weiss, Sara Rolandsson Enes
Current Stem Cell Reports (2023) Vol. 10, Iss. 2, pp. 9-19
Open Access | Times Cited: 1
Dissecting the Interrelationship between COVID‐19 and Diabetes Mellitus
Pratiksha H. Roham, Jayesh Kamath, Shilpy Sharma
Advanced Biology (2023) Vol. 7, Iss. 8
Closed Access
Page 1 - Next Page

Scroll to top